Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Agios Pharmaceuticals Inc...

    NASDAQ: AGIO · Real-Time Price · USD
    35.50
    1.20 (3.50%)
    At close: Jun 16, 2025, 3:59 PM
    35.06
    -1.24%
    After-hours: Jun 16, 2025, 04:17 PM EDT

    Agios Pharmaceuticals Statistics

    Share Statistics

    Agios Pharmaceuticals has 57.92M shares outstanding. The number of shares has increased by 0.92% in one year.

    Shares Outstanding

    n/a
    		 57.92M

    Shares Change (YoY)

    n/a
    		 0.92%

    Shares Change (QoQ)

    n/a
    		 0.47%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 55.44M

    Failed to Deliver (FTD) Shares

    n/a
    		 492

    FTD / Avg. Volume

    n/a
    		 0.08%

    Short Selling Information

    The latest short interest is 4.25M, so 7.34% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.25M

    Short % of Shares Out

    n/a
    		 7.34%

    Short % of Float

    n/a
    		 7.39%

    Short Ratio (days to cover)

    n/a
    		 7.23

    Valuation Ratios

    The PE ratio is 2.77 and the forward PE ratio is -5.17. Agios Pharmaceuticals's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 2.77

    Forward PE

    n/a
    		 -5.17

    PS Ratio

    n/a
    		 51.15

    Forward PS

    n/a
    		 2.1

    PB Ratio

    n/a
    		 1.21

    P/FCF Ratio

    n/a
    		 -4.77

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Agios Pharmaceuticals has an Enterprise Value (EV) of 1.85B.

    EV / Sales

    n/a
    		 50.62

    EV / EBITDA

    n/a
    		 -4.34

    EV / EBIT

    n/a
    		 -4.74

    EV / FCF

    n/a
    		 -4.72

    Financial Position

    The company has a current ratio of 11.9, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 11.9

    Quick Ratio

    n/a
    		 11.56

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.13

    Debt / FCF

    n/a
    		 -0.15

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 43.72% and Return on Invested Capital is -24.99%.

    Return on Equity

    n/a
    		 43.72%

    Return on Assets

    n/a
    		 40.51%

    Return on Invested Capital

    n/a
    		 -24.99%

    Revenue Per Employee

    n/a
    		 $75,098.77

    Profits Per Employee

    n/a
    		 $1,386,265.43

    Employee Count

    n/a
    		 486

    Asset Turnover

    n/a
    		 0.02

    Inventory Turnover

    n/a
    		 0.15

    Taxes

    Income Tax

    n/a
    		 44.24M

    Effective Tax Rate

    n/a
    		 6.16%

    Stock Price Statistics

    The stock price has increased by -16.65% in the last 52 weeks. The beta is 0.73, so Agios Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.73

    52-Week Price Change

    n/a
    		 -16.65%

    50-Day Moving Average

    n/a
    		 29.82

    200-Day Moving Average

    n/a
    		 38.1

    Relative Strength Index (RSI)

    n/a
    		 72.77

    Average Volume (20 Days)

    n/a
    		 615,250

    Income Statement

    In the last 12 months, Agios Pharmaceuticals had revenue of 36.5M and earned 673.73M in profits. Earnings per share was 11.86.

    Revenue

    n/a
    		 36.5M

    Gross Profit

    n/a
    		 32.33M

    Operating Income

    n/a
    		 -425.74M

    Net Income

    n/a
    		 673.73M

    EBITDA

    n/a
    		 -425.74M

    EBIT

    n/a
    		 -425.74M

    Earnings Per Share (EPS)

    n/a
    		 11.86
    Full Income Statement

    Balance Sheet

    The company has 76.25M in cash and 56.99M in debt, giving a net cash position of 19.26M.

    Cash & Cash Equivalents

    n/a
    		 76.25M

    Total Debt

    n/a
    		 56.99M

    Net Cash

    n/a
    		 19.26M

    Retained Earnings

    n/a
    		 -148.92M

    Total Assets

    n/a
    		 1.56B

    Working Capital

    n/a
    		 916.25M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -389.84M and capital expenditures -1.69M, giving a free cash flow of -391.53M.

    Operating Cash Flow

    n/a
    		 -389.84M

    Capital Expenditures

    n/a
    		 -1.69M

    Free Cash Flow

    n/a
    		 -391.53M

    FCF Per Share

    n/a
    		 -6.89
    Full Cash Flow Statement

    Margins

    Gross margin is 88.59%, with operating and profit margins of -1166.47% and 1845.92%.

    Gross Margin

    n/a
    		 88.59%

    Operating Margin

    n/a
    		 -1166.47%

    Pretax Margin

    n/a
    		 1967.15%

    Profit Margin

    n/a
    		 1845.92%

    EBITDA Margin

    n/a
    		 -1166.47%

    EBIT Margin

    n/a
    		 -1166.47%

    FCF Margin

    n/a
    		 -1072.73%

    Dividends & Yields

    AGIO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 36.09%

    FCF Yield

    n/a
    		 -20.97%
    Dividend Details

    Analyst Forecast

    The average price target for AGIO is $56.5, which is 59.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $56.5

    Price Target Difference

    n/a
    		 59.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 85.08

    Graham Upside

    n/a
    		 139.66%

    Scores

    Altman Z-Score

    n/a
    		 11.62

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist